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through loss of function genetic screens in Drosophila melanogaster; the Hpo gene, after which the pathway has been called, was named for the mutant overgrown head phenotype that resembled hippopotamus hide [9] .
Hippo pathway components
The core elements of the Hippo pathway are well known but additional components constituting an extended network continue to be identified. Core components of the vertebrate pathway ( When the Hippo pathway is inactivated, YAP and TAZ translocate to the nucleus where they behave as co-activators for various transcription factors. YAP and TAZ lack a DNA binding domain and so influence transcription by interacting with DNA binding proteins.
Organ growth is promoted by the interaction of YAP and TAZ with TEAD family transcription factors which upregulate transcription of genes that promote cell proliferation, survival, differentiation and morphogenesis [10] . TEAD transcription factors are ubiquitously expressed, though each TEAD protein (TEAD1-TEAD4) occupies a slightly different niche with respect to tissue expression and developmental stage.
Knowledge of upstream signals that regulate organ size and morphology is key to understanding and modulating the Hippo pathway. Recent studies have highlighted the influence of cell contacts on regulation of Hippo and associated pathways. The Crumbs (Crb) complex, which is associated with tight junctions in the sub-apical region of the cell membrane, regulates the Hippo pathway in Drosophila through interactions with the upstream Hippo regulator Expanded (Ex) [11] . It is unclear whether the Crb-Ex mechanism is conserved in mammals but, in response to high cell density, Crb can directly inhibit nuclear translocation of YAP (Fig. 1) , in addition to contributing to Hippo pathway activation through an unidentified mechanism [12] . E-cadherin, a transmembrane protein that forms the intercellular epithelial junction complex, was recently found to be an upstream regulator of the Hippo pathway. E-cadherin induces cell contact inhibition, a phenomenon that stops cellular proliferation upon confluence. E-cadherin recruits to the cell membrane; β-catenin then activates the Hippo pathway through interactions with Merlin/NF2 [13] .
Organ growth control and tumourigenesis
Hippo signalling orchestrates organ growth through its coordination of cell proliferation, survival, differentiation and polarity. Numerous examples have illustrated that deregulation of the pathway leads to significantly increased organ size. Upregulation of YAP, the target protein that is inhibited by the Hippo pathway, increased mouse liver size from around 5% of body weight to around 25% in four weeks [14] . Similarly, when core Hippo pathway proteins MST1/2 and Sav1 were knocked out in mouse livers, the organs were significantly larger than those of wild-type mice [15] [16] [17] [18] . An enlarged heart phenotype has also been observed in Sav1 knockout mice [19] . In all cases, organ structure was preserved, as observed previously for Drosophila Hippo pathway mutants which also display enlarged organs (heads, imaginal discs) with normal tissue patterns [20] .
Constitutive YAP over-expression or liver-specific deletion of MST1/2 or Sav1 induces multi-focal tumourigenesis, highlighting the role of the pathway in tumour suppression [14, [16] [17] [18] . YAP and TAZ can induce anchorage-independent growth and epithelialmesenchymal transition (EMT) of immortalised mammary and pancreatic epithelial cells [12] . EMT is important in normal morphological processes but when deregulated in cancers is involved in metastasis, tumour recurrence and therapeutic resistance. Upstream Hippo pathway components function as tumour suppressors. Hippo pathway mutations have been observed in a range of human cancers including breast cancers, soft tissue sarcomas, melanomas, colorectal cancers, ovarian carcinomas, retinoblastomas, astrocytomas, and neurofibromatosis type 2 [1, 5] . There has been speculation about the possible involvement of Hippo signalling in cancer stem cells due to the pathway's links to stem cell self-renewal and cancer; recently the Hippo pathway, via TAZ, was identified as a molecular link between EMT, cell polarity and cancer stem cells in breast cancer [21] .
Integration of multi-pathway signalling
The Hippo pathway interacts with numerous other signalling pathways (Table 1) , some of which contribute to organ growth regulation. This cross-talk occurs in both cytoplasm and nucleus and is probably important for the tight control of cell proliferation, growth, polarity and differentiation required for formation and maintenance of functional proportionate organs without crossing the boundary into tumourigenesis. Some of the inter-connections with the Hippo pathway are described below [2, 7, 8, 22] .
Canonical Wnt pathway
Wnt signalling activates membrane-bound Dishevelled (Dvl) which inhibits the axin/GSK-3/APC β-catenin destruction complex (β-catenin is the nuclear effector of Wnt signalling). When membrane-localised β-catenin dissociates from E-cadherin and α-catenin, it translocates to the nucleus where it interacts with Lef/Tcf transcription factors, causing the activation of target genes that determine stem cell survival and differentiation. The Hippo pathway inhibits the canonical Wnt pathway by enhancing levels of cytoplasmic phosphorylated TAZ, which binds to Dvl [23] . This interaction prevents Dvl phosphorylation, rendering Dvl inactive. In the absence of hyperphosphorylated Dvl, β-catenin does not reach the nucleus and is targeted for degradation.
The links between Hippo and Wnt signalling are not limited to the cytoplasmic TAZ-Dvl interaction; the E-cadherin/β-catenin/α-catenin complex binds Merlin and activates the Hippo pathway [13] . Also, upon Hippo pathway abrogation, nuclear non-phosphorylated TEAD-bound YAP forms a complex with Lef/Tcf-bound β-catenin. YAP-β-catenin complex formation leads to up-regulation of Sox2 and Snai2 genes and consequent increase in heart size [19] .
TGFβ and BMP signalling
The Hippo pathway has multiple connections with TGFβ and BMP signalling. Upon The Hippo pathway regulator E-cadherin can control Rho activation, but in this case Ecadherin may not be involved as mechanotransduction-mediated control of YAP/TAZ cellular localisation occurs independently of the core Hippo pathway [25] .
Pro-apoptotic and other interactions
In addition to TEADs and Smads, YAP and TAZ interact with other transcription factors, for example PPARγ and p73, which can result in repressed transcription or pro-apoptotic effects. YAP and TAZ interact with a host of other proteins (Table 2) , in some cases without any apparent connection to the canonical Hippo pathway. As YAP and TAZ are the most downstream targets of the pathway, elucidating the function of these YAP/TAZ complexes is vital for understanding the control of organogenesis and tissue homeostasis.
Key Hippo pathway domains
Regulation of organ growth, tissue homeostasis, tissue regeneration and stem cell selfrenewal by Hippo pathway components depends on protein-protein, protein-nucleic acid and protein-membrane interactions and in some instances multi-protein complex formation. The binding properties of a range of domains or motifs within Hippo pathway proteins promote these interactions. Hippo pathway proteins generally contain multiple domains or motifs separated by various lengths of often unstructured polypeptide (Fig. 2) .
TEAD-YAP/TAZ interaction domains
The major nuclear proteins regulated by the Hippo pathway are the TEAD transcription factors ( mutant DBD comprises a three-helix bundle in a homeodomain-like fold. The first two α-helices are almost anti-parallel with the third α-helix lying across them (Fig. 3) . Similar to homeodomain proteins, DNA binding is mediated by the third α-helix (H3) and the preceding loop (L2); H1 and L1 do not bind directly but are necessary for full strength binding of TEAD to tandem M-CAT sites [26] .
The TEAD-binding domain (TBD) of YAP/TAZ, located in the N-terminal region, is natively unstructured and binds TEAD with high fidelity -to date no other protein interactions are known to involve the TBD. The crystal structures of YAP-TEAD interaction domains involving human TEAD2 [27] , human TEAD1-YAP [28] and mouse TEAD4-YAP [29] show that the TEAD YBDs adopt an immunoglobulin-like β-sandwich fold with the addition of two helix-turn-helix motifs (Fig. 3) . The Y421H mutation in TEAD1 that is present in human Sveinsson's chorioretinal atrophy was previously found to abrogate interactions with YAP and TAZ [30] . Consistent with this, Y421 is located in the TEAD-YAP interface where it forms a hydrogen bond with a Ser residue in YAP (S94 in human YAP). Upon interaction with TEAD, YAP TBD forms two α-helices that pack into binding grooves and are separated by an extended loop that wraps around the YBD [28, 29] .
YAP/TAZ transcription activation domain (TAD)
Both YAP and TAZ contain a C-terminal TAD [31] . Although there have been no experimental studies of the structure of this domain, secondary structure predictions indicate that it is largely unstructured.
YAP/TAZ cytoplasmic sequestration by 14-3-3
C-terminal to the YAP/TAZ TBD is an HxRxxS motif that becomes a 14-3-3 binding site upon Ser phosphorylation (S127 in human YAP). A crystal structure of the homodimeric 14-3-3σ:YAP phospho-peptide complex (Fig. 3) reveals that the YAP peptide binds to each monomer of 14-3-3σ with 1:1 stoichiometry, so each 14-3-3 dimer can bind two molecules of YAP [32] . 14-3-3σ dimerises in a W-shape via α-helices 1-4. Helices 3, 5, 7, and 9 on each monomer form the YAP-binding groove. The YAP peptide-bound 14-3-3σ structure is very similar to unbound 14-3-3σ with an overall r.m.s.d. (root mean square deviation) between the structures of of 1.00 Å, suggesting that YAP binding does not induce a large conformational change in 14-3-3.
WW domains
WW domains are prevalent and important features of the Hippo pathway: YAP, TAZ, Sav1, Kibra and Itch each contain at least one WW domain [33] . The WW domain (approximately 40 residues) is the smallest known protein domain and consists of a twisted three-stranded β-sheet (Fig. 3) . WW domains are named after two signature Trp residues located on the first and third β-strands. The first Trp is required for folding and the second Trp is involved in ligand binding [34] . (Table 2 ) many of which bind via at least one of the WW domains; given the prevalence of PPxY motifs in proteomes, the number of protein-protein interactions mediated by YAP and TAZ could be much higher than this.
The WW domains of YAP and TAZ belong to group I [37] , but YAP WW1 has also been found to interact with a phospho-serine motif of Smad1 [24] : phosphorylation by CDK8/9 (as part of BMP signalling) creates a YAP WW1 binding site on the Smad1 inter-MH domain linker (see "TGFβ and BMP signalling" above). This region also contains a PPxY motif that binds to YAP WW2. CDK8/9 phosphorylation also primes Smad1 for phosphorylation by GSK3. Secondary phosphorylation of Smad1 by GSK3 reduces the affinity for YAP WW1 and increases the affinity for Smurf1 WW1; Smurf1 WW2 simultaneously binds the PPxY motif. Interactions with Smurf1 lead to polyubiquitination and subsequent proteasomal degradation of Smad1, thereby marking the end of a YAP-Smad transcriptional event. Wnt signalling suppresses GSK3, providing another illustration of the complexity of inter-pathway connections.
SARAH domains
The SARAH coiled coil domain is present in the C-terminal region of Sav1, Rassf and Hippo (MST1/2). SARAH domains homodimerise and can also mediate heterodimerisation of Hippo pathway proteins, for example between MST1/2 and Sav1.
The solution structure of human MST1 SARAH homodimer (Fig. 3) shows that each monomer comprises a short N-terminal α-helix that is oriented towards the N-terminal helix of the other monomer, and an elongated C-terminal α-helix along which the antiparallel dimer interface lies [38] . The Rassf5 (Nore1) SARAH domain forms a homotetramer but in the presence of MST1 SARAH domain only dimers are observed.
The role of mammalian Rassf proteins in the Hippo pathway is currently unclear; in vitro studies indicate that Rassf1 and Rassf5 inhibit the Hippo pathway, as is the case for
Drosophila Rassf. Conversely, in some cases the Hippo pathway seems to be activated by Rassf proteins in vivo [1] .
Ser/Thr kinase domains
Central to the Hippo pathway are the Ser/Thr kinase domains of MST1/2 and LATS1/2 that propagate phosphorylation events to retain YAP/TAZ in the cytoplasm. MST1/2 belong to the Ste group of kinases, whereas LATS kinases are similar to the PKC family.
In a crystal structure of activated MST1 (Fig. 3) , the auto-activation loop is diphosphorylated. There are currently no published structures of the LATS1 and LATS2 kinase domains.
MOB1
MOB1 is part of the Mps One binder (MOB) family of co-activator proteins [39] . Human MOB1 binding to LATS1/2 triggers LATS1/2 auto-phosphorylation on the activation segment. The MOB1-LATS1/2 complex phosphorylates YAP/TAZ. The C-terminal core domain adopts an α-helical fold common to all MOB proteins whereas the N-terminal region is less conserved but seems to be functionally important. In S. cerevisiae MOB1, this N-terminal region includes structural elements that mediate homodimerisation in vitro [40] . One side of the MOB1 surface is mostly acidic and the opposite side is basic.
Bioinformatic and experimental analyses indicate that the interaction between MOB1 and LATS1/2 is mediated by the acidic face of the former and the basic region of the Nterminal regulatory domain of the latter.
PDZ binding motifs
YAP and TAZ contain a C-terminal PDZ binding motif (LTWL) that allows interaction with several proteins involved in organ size regulation. PDZ domains typically comprise 80-100 residues forming six β-strands, and two α-helices of differing lengths (Fig. 3) .
The binding groove is generally located between the longer α-helix and the second β-strand [41] . Nuclear localization of YAP/TAZ is promoted by interactions with the first PDZ domain of the tight junction-associated proteins Zonula Occludens-1 and -2 [42, 43] . Interactions involving PDZ binding motifs and PDZ domains, and WW domains and PPxY motifs, are important for Hippo pathway cross-talk with TGFβ signalling (YAP/TAZ interaction with Crumbs components PALS1, AMOT, PATJ and LIN7 [12] ) and with the Wnt pathway (TAZ interaction with Dvl [23] ).
Other domains within Hippo pathway proteins
Remaining protein-protein interaction domains include those involved in self-association such as the dimerisation domain of α-catenin and those that lead to proteasomal degradation e.g. the ubiquitin-associated (UBA) domain of LATS1/2. Domains involved in membrane interaction and localisation include the FERM domains in Merlin and FRMD6, and the C2 domains in Kibra and Itch.
Conclusion
The Hippo pathway inter-connects with numerous other pathways in order to orchestrate organ growth or tissue regeneration, and might therefore be more appropriately termed 
Summary
• The Hippo pathway is a central, conserved pathway that interconnects with several other pathways to regulate organ growth, tissue homeostasis and regeneration, and stem cell self-renewal.
• The Hippo pathway is unique in its capacity to orchestrate the multiple processes, from sensing to execution, necessary for organ expansion.
• The mechanisms and effects of Hippo pathway cross-talk with other pathways such as Wnt and TGFβ growth factor pathways will undoubtedly turn out to be highly complex but are gradually being elucidated.
• The Hippo pathway includes protein domains involved in catalysis, proteinmembrane interaction, protein-protein interaction, and protein-nucleic acid interaction. The transcription factor E2F is negatively regulated by Rb. E2F interacts with the Yki-Sd complex and therefore Rb inhibits E2F-Yki-Sd mediated transcription. In humans, LATS phosphorylates DYRK (dual-specificity tyrosine phosphorylation-regulated kinases) which leads to activation of the 'DREAM' complex and inhibition of E2F. 
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